REQUEST A DEMO
Total
USD $0.00
Search more companies

Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. (Singapore)

Main Activities: Ambulatory Health Care Services | Management, Scientific, and Technical Consulting Services
Full name: Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. Profile Updated: December 15, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. is engaged in providing healthcare solutions for Metabolic, Cardiovascular, Gastrointestinal and Respiratory problems. In addition, the company is responsible in supervising the strategic and commercial operations of the local management team across Australia, Thailand, the Philippines, Indonesia, India, Malaysia and Singapore.

Headquarters
21 Biopolis Road #04-01/12 Nucleos Singapore 138567
Singapore; Singapore; Postal Code: 138567

Contact Details: Purchase the Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. report to view the information.
Incorporation Date:
February 13, 2009
Key Executives
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Takeda Pharmaceuticals (Hong Kong) Limited (Hong Kong SAR, China)
Company Performance
Financial values in the chart are available after Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Total operating revenue
0.79%
Net Profit (Loss) for the Period
102.55%
Total assets
5.33%
Total equity
1.85%
Return on Equity (ROE)
0.9%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?